Cargando…
Predicting dynamic response to neoadjuvant chemotherapy in breast cancer: a novel metabolomics approach
Neoadjuvant chemotherapy (NACT) outcomes vary according to breast cancer (BC) subtype. Since pathologic complete response is one of the most important target endpoints of NACT, further investigation of NACT outcomes in BC is crucial. Thus, identifying sensitive and specific predictors of treatment r...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297806/ https://www.ncbi.nlm.nih.gov/pubmed/35338693 http://dx.doi.org/10.1002/1878-0261.13216 |